Apply to cuts, scrapes, sunburn, post shaving & more
Studies show oral semaglutide produces meaningful weight loss, with many users losing 10-15% of body weight over 68 weeks
However, this weight loss drug is not without challenges
Building upon these findings, we conducted this longitudinal investigation using an extensive global medical records database to explore the associations between GLP-1 RAs and mortality, adverse cardiovascular and kidney-related events in a substantial cohort of individuals with type 2 diabetes concomitant with AKD
NHS-licensed options such as semaglutide or tirzepatide should be discussed with a GP for weight management
Ilic S, Drmic D, Franjic S, Kolenc D, Coric M, Brcic L, et al